Patents by Inventor Steinthor SIGURDSSON

Steinthor SIGURDSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for enhancing beta-adrenergic response
    Patent number: 11850257
    Abstract: The present invention provides cnidimoside A for use in the treatment of urinary conditions such as overactive bladder and related syndromes. The invention also relates to methods of treatment of overactive bladder using cnidimoside A. The compound can be administered purified or as a plant extract.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: December 26, 2023
    Assignee: SAGANATURA EHF.
    Inventor: Steinthor Sigurdsson
  • METHOD FOR ENHANCING BETA-ADRENERGIC RESPONSE
    Publication number: 20220202840
    Abstract: The present invention provides cnidimoside A for use in the treatment of urinary conditions such as overactive bladder and related syndromes. The invention also relates to methods of treatment of overactive bladder using cnidimoside A. The compound can be administered purified or as a plant extract.
    Type: Application
    Filed: February 11, 2020
    Publication date: June 30, 2022
    Inventor: Steinthor SIGURDSSON